Related Experiment Video
Updated: Jun 14, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Autologous ring vs. flexible prosthetic ring for ischemic mitral regurgitation
Ali Reza Bakhshandeh1, Mehrdad Salehi, Hasan Radmehr
1Imam Khomeini Medical Center, Tehran, Iran. abakhshandeh18@yahoo.com
Asian Cardiovascular & Thoracic Annals
|March 23, 2010
Summary
Autologous annuloplasty rings offer a cost-effective, readily available alternative for mitral valve repair in ischemic mitral regurgitation. Short-term results show comparable efficacy to commercial prostheses, making them a viable option.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery
- Heart Valve Repair
Background:
- Ischemic mitral regurgitation is commonly treated with ring annuloplasty.
- Commercial annuloplasty rings may be inaccessible or costly.
- Autologous annuloplasty rings can be fabricated by surgeons as an alternative.
Purpose of the Study:
- To compare the short-term outcomes of mitral valve repair using autologous annuloplasty rings versus the SJM Tailor flexible prosthesis.
- To evaluate the efficacy and durability of autologous rings in ischemic mitral regurgitation.
Main Methods:
- A randomized study involving 100 patients undergoing coronary artery bypass grafting and mitral ring annuloplasty for ischemic regurgitation.
- Patients were assigned to either autologous annuloplasty rings or the SJM Tailor flexible prosthesis.
- Transesophageal and transthoracic echocardiography were used to assess repair success and durability at 3, 6, and 9 months postoperatively.
Main Results:
- No significant differences were observed between autologous rings and the SJM Tailor prosthesis in immediate repair success.
- Echocardiographic assessments showed comparable durability for both techniques at 3, 6, and 9 months postoperatively.
- Autologous rings demonstrated ease of creation, cost-effectiveness, and consistent availability.
Conclusions:
- Autologous annuloplasty rings represent an acceptable and effective alternative to commercial prostheses for mitral valve repair in ischemic mitral regurgitation.
- The findings support the use of autologous rings, particularly when commercial options are limited.
- This approach offers a practical solution for improving patient outcomes in resource-constrained settings.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.